Use of CNP-22, alone1 or in combination with physalemin, as a therapeutic agent
Details for Australian Patent Application No. 2008309993 (hide)
International Classifications
Event Publications
22 April 2010 PCT application entered the National Phase
PCT publication WO2009/046861 Priority application(s): WO2009/046861
20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008309996-Use of the human pancreatic polypeptide as a therapeutic agent
2008309951-Method and apparatus for generating a binaural audio signal
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser